-

Astra Space, Inc. Investor News: Robbins LLP is Investigating Astra Space, Inc. (ASTR) f/k/a Holicity Inc. (HOL)

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Astra Space, Inc. (NASDAQ: ASTR) f/k/a Holicity Inc. (NASDAQ: HOL) and its officers and directors to determine if they breached their fiduciary duties and violated securities laws in connection with its ability to successfully launch. Astra Space purportedly operates as an operational space launch company.

If you would like more information about our investigation of Astra Space, Inc.'s misconduct, click here.

What is this Case About: Astra Space, Inc. (ASTR) Misled the Investing Public About its Business Prospects

According to a class action complaint filed against Astra Space, on June 30, 2021, Astra Space and Holicity Inc., a special purpose acquisition company, merged. During the class period, defendants touted the Company's ability to launch "anywhere in the world in 24 hours" and overstated the effectiveness and reliability of its designs, among other things.

On December 29, 2021, researcher Kerrisdale Capital released a report entitled "Astra Space, Inc. (ASTR): Headed for Dis-Astra," which alleged myriad issues with the Company. The report explained that Astra cannot launch from "anywhere in the world." In the U.S., for example, Astra can only launch from a FAA-licensed commercial spaceport approved for vertical launch. Further, the report indicated that Astra's forecast of 300 launches per year is highly speculative for many reasons, not the least of which is lack of market demand. The report noted that Astra has had only one successful orbital test flight and examined Astra's design failures. On this news, shares of Astra stock fell $1.10 per share, or approximately 14%, to close at $6.61 per share on December 29, 2021.

Next Steps: Astra Space, Inc. (ASTR) shareholders have legal options. If you own shares of Astra Space, contact us for more information about your legal rights.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Astra Space, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:ASTR

Release Summary
Astra Space, Inc. (ASTR) Misled the Investing Public About its Business Prospects
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the uniQure N.V. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that un...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic diseases in China." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Alleg...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus (“HPV”). For more information, submit a...
Back to Newsroom